Soaring Eagle Acquisition EBIT

Soaring Eagle Acquisition (SRNG) currently reports a EBIT of $-210M as of June 2026. That compares with $-380M in the prior-year period — up 45.0% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Soaring Eagle Acquisition's EBIT history and peer comparisons.

Soaring Eagle Acquisition's EBIT increased from $-380M to $-210M — a 45.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Soaring Eagle Acquisition's EBIT of $-210M is lower than the Healthcare sector average of $23B. That is roughly 100.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Soaring Eagle Acquisition reported $-210M in EBIT as of June 2026. That compares with $-380M in the prior-year period — up 45.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-210M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Soaring Eagle Acquisition, and consider following SRNG for alerts when major investors trade the stock.